Be Patient with Zimmer Holdings

Zimmer Holdings (ZMH), a global leader in reconstructive orthopedic implants (for example, hip and knee replacements), has posted solid earnings growth and price appreciation since it was spun off from Bristol-Myers Squibb in 2002. ZMH climbed from $28 to a peak of $88.90 on July 8, 2004.

As of April 8, 2005 the stock appears to have made a double top and looks to be on the downside.

Avoid the stock for now but when the downside is over, ZMH would be a great stock for a long-term growth portfolio